Fingerprint
Dive into the research topics of 'AMC 048: Modified CODOX-M/IVAC-rituximab is safe and effective for HIV-associated Burkitt lymphoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
AMC 048: Modified CODOX-M/IVAC-rituximab is safe and effective for HIV-associated Burkitt lymphoma
AIDS Malignancy Consortium
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- Institute of Clinical and Translational Sciences
- Siteman Cancer Center
- Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs)
- Section of Molecular Oncology & Developmental Therapeutics
- Division of Oncology
- DBBS - Molecular Microbiology and Microbial Pathogenesis
- DBBS - Molecular Genetics and Genomics
- DBBS - Cancer Biology
Research output: Contribution to journal › Article › peer-review
63
Scopus
citations